News search
 Research 4 Nov 2026 A study involving CNIC researchers shows that blood vessels can grow in the absence of VEGF-VEGFR2 signalling, one of the pathways most commonly targeted for therapeutic purposes in clinical practice. |
 About the CNIC 4 Sep 2026 The research demonstrates the benefit of a new gene silencer for treating the disease |
 |
 Research 7 Jul 2026 Hypertrophic cardiomyopathy is the most common inherited heart disease and the leading cause of sudden cardiac death in young people and athletes |
 |
 Research 30 Apr 2026 Faseeha Ayaz, senior Editor Nature Communications, Springer Nature |
 Research 16 Feb 2026 A new CNIC-led study shows that a genetic tool derived from baker’s yeast enables human cells to manufacture the building blocks of DNA even when their mitochondria fail. |
 Research 2 Dec 2025 An international team has published NeuMap, the first atlas to reveal the global architecture of neutrophils, showing how this “first line of defense” reorganizes to protect, remember, and heal. |
 Research 16 Jul 2025 A new study led by the CNIC has identified imidazole propionate (ImP), a metabolite produced by gut bacteria, as a driver of atherosclerosis— as a driver of atherosclerosis, the disease behind most heart attacks and strokes |
 Research 5 Jun 2025 This new tool will advance the development of treatments for congenital muscle diseases and cardiomyopathies. |
- 1 of 8
- next ›
